Pharma
Health is wealth, and these carefully selected pharmaceutical companies could help your portfolio grow. Our professional analysts have handpicked these stocks from an industry that's projected to reach $1.9 trillion by 2027.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Unlock all stocks by downloading the app for FREE.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Pharmaceutical companies offer a unique combination of stability and growth potential. With consistent demand for healthcare and ongoing innovation in treatments, this industry is projected to grow at 7% annually, reaching $1.9 trillion by 2027.
What You Need to Know
These pharma stocks represent companies focused on developing life-improving and life-saving medications. The healthcare sector tends to be more resilient during economic downturns, as medical needs remain constant regardless of market conditions.
Why These Stocks
This collection includes established pharmaceutical giants alongside innovative biotech companies. These stocks were selected based on their market leadership, research capabilities, and potential for growth through new treatments and medications.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+53.53%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 53.53% over the next year.
Stocks Rated Buy by Analysts
14 of 23 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Healthcare's Golden Opportunity
The pharma industry is expected to reach $1.9 trillion by 2027. Getting in now means you could benefit from this massive growth trajectory as companies develop new treatments.
Innovation Worth Watching
Companies like Moderna and Novavax showed how pharmaceutical breakthroughs can lead to extraordinary gains. These stocks represent the future of healthcare innovation.
Recession-Resistant Potential
Healthcare needs remain constant regardless of economic conditions, making pharma stocks potentially more stable during market downturns while still offering growth.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
AI's App Store Showdown
Elon Musk's threat of an antitrust lawsuit against Apple highlights the growing tension between AI developers and the powerful app store gatekeepers. This situation could create opportunities for other technology companies that offer alternative platforms or help developers navigate the competitive app landscape.
Navigating The Fed's Inflation Dilemma
A recent spike in inflation, driven by import tariffs, has put the Federal Reserve in a difficult position. This theme focuses on companies that could benefit from this economic tension, whether through competitive pricing or a potential interest rate cut.
Grounded Giant: Rivals Poised To Gain From Air Canada Strike
A potential strike at Air Canada threatens to ground the nation's largest airline, creating significant travel disruption. This presents a tactical opportunity for rival airlines to capture market share and benefit from the surge in demand from displaced travelers.
Frequently Asked Questions
Everything you need to know about the product and billing.